Focal Therapy for Prostate Cancer

As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression.
Recorded on 03/09/2024. [Show ID: 39760]
Donate to UCTV to support informative & inspiring programming:
www.uctv.tv/do...
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
More videos from: Prostate Cancer Patient Conference
(www.uctv.tv/pr...)
Explore More Health & Medicine on UCTV
(www.uctv.tv/he...)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service - by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(www.uctv.tv)

[@Jack-2day]

This talk is pretty much the one you presented back in Oct of 2022. Just curious as to whether there is any further research/stats etc since that time? In particular regarding Tulsa focal therapy. Thank you

[@wilander1]

Would appreciate hearing your thoughts on MRI LINAC. Do you think this will be the future gold standard in high dose radiation delivery?

[@maxstyle3286]

I am aged 66 . My PSA is 4.1 The MRI prostate w wo contrast RAD showed 4 and the biopsy report from 12 samples showed one RA , biopsy 3+3 and one RMPZ biopsy 4+3 . The bone scan showed no spread . Am i considered as Intermediate Risk Prostate Cancer ? Should i do Radiation therapy with or without hormone therapy ?

[@MM-sf3rl]

Today I watched Dr. Arvin George Johns Hopkins and Dr. Matthew Cooperberg from UCSF on Back Table Urology CZcams Channel. Granted, I’m not doctor, but Gleason 4+3=7 in called Unfavorable Intermediate, as apposed to Favorable Intermediate which is Gleason 3+4=7 (there may be some other qualifiers). Some institutions, like Johns Hopkins and UCSF do ablation therapy for 4+3, but there are another dozen or more considerations to quality you for ablation therapy. I suggest getting 2-3 opinions and do your own research. Another excellent Doctor is Mark Emberton at University of College of London. His trial study was published in 2022 on about 1,400 men who had HIFU ablation therapy and survival rates.